Park S-J, Ahn J-M, Kang D-Y, et al. Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial. Lancet 2024; 403: 1753–65—In table 2 of this Article, the proportion of patients in the optimal medical therapy group with target-vessel-related myocardial infarction at 4 years should have been 0·9%. This correction has been made to the online version as of Nov 14, 2024.

中文翻译：

---

 错误部门


Park SJ， Ahn JM， Kang D-Y， et al. 预防性经皮冠状动脉介入治疗与单独最佳药物治疗治疗脆弱性动脉粥样硬化性冠状动脉斑块 （PREVENT）：一项多中心、开放标签、随机对照试验。柳叶刀 2024;403： 1753–65—在本文的表 2 中，最佳药物治疗组中 4 年时靶血管相关心肌梗死的患者比例应为 0·9%。此更正已于 2024 年 11 月 14 日对在线版本进行。